Survodutide

Survodutide (BI 456906) is an investigational peptide studied for its activity at the glucagon receptor (GCGR) and GLP-1 receptor (GLP-1R). It is a modified peptide designed for longer duration of action and has been evaluated in clinical research related to metabolic and endocrine signaling pathways.